Brian G. Lloyd - 28 Feb 2023 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF LEGAL OFFICER, SECRETARY
Signature
/s/ Brian G. Lloyd
Issuer symbol
MMSI
Transactions as of
28 Feb 2023
Net transactions value
-$219,292
Form type
4
Filing time
02 Mar 2023, 19:22:45 UTC
Previous filing
08 Feb 2023
Next filing
14 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +10,183 +99% $0.000000 20,477 28 Feb 2023 Direct F1
transaction MMSI Common Stock, No Par Value Tax liability $219,292 -3,107 -15% $70.58 17,370 28 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Award $0 +13,576 $0.000000 13,576 28 Feb 2023 Common Stock 13,576 $70.58 Direct F3
holding MMSI Non-qualified stock options (right to buy) 25,000 28 Feb 2023 Common Stock 25,000 $44.80 Direct F4
holding MMSI Non-qualified stock options (right to buy) 30,000 28 Feb 2023 Common Stock 30,000 $55.73 Direct F5
holding MMSI Non-qualified stock options (right to buy) 16,722 28 Feb 2023 Common Stock 16,722 $37.71 Direct F6
holding MMSI Non-qualified stock options (right to buy) 9,681 28 Feb 2023 Common Stock 9,681 $56.25 Direct F7
holding MMSI Non-qualified stock options (right to buy) 8,094 28 Feb 2023 Common Stock 8,094 $65.03 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.26.2020 and 03.19.2021.
F2 These shares were not sold in an open-market transaction.
F3 Become exercisable in equal annual installments of 25% commencing on 02/28/2024.
F4 Become exercisable in equal annual installments of 20% commencing on 03/02/2019.
F5 Become exercisable in equal annual installments of 20% commencing on 03/01/2020.
F6 Become exercisable in equal annual installments of 25% commencing on 02/26/2021.
F7 Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
F8 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.